Biotechnology
Medical
Biopharmaceutical
Puma Biotechnology
$10.489876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$10.48
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.31 (-2.87%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours
Why Robinhood?
You can buy or sell PBYI and other stocks, options, ETFs, and crypto commission-free!
About PBYI
Puma Biotechnology Inc Common Stock, also called Puma Biotechnology, is a development stage biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. Read More The company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. Puma Biotechnology was founded by Alan H. Auerbach on September 15, 2010 and is headquartered in Los Angeles, CA.
Employees
272
Headquarters
Los Angeles, California
Founded
2010
Market Cap
416.20M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
1.13M
High Today
$11.11
Low Today
$10.41
Open Price
$10.92
Volume
1.21M
52 Week High
$54.20
52 Week Low
$10.41
Collections
Biotechnology
Medical
Biopharmaceutical
Pharmaceutical
Health
Cancer Prevention
Technology
Price Paid on Robinhood
54% Lower
Right Now
52 Week Low
$10.41
Average Price Paid
$22.72
52 Week High
$54.20
Analyst Ratings
0%
of 10 ratings
Buy
0%
Hold
70%
Sell
30%
PBYI Earnings
-$1.98
-$1.41
-$0.83
-$0.26
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Aug 8, After Hours